ADVANCED SOLID MALIGNANCY
Clinical trials for ADVANCED SOLID MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID MALIGNANCY trials appear
Sign up with your email to follow new studies for ADVANCED SOLID MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a combination of three drugs—vemurafenib, cetuximab, and irinotecan—in 47 people with advanced solid tumors that have a specific BRAF V600 mutation and could not be removed by surgery or had spread. The main goal was to find the safest dose and under…
Matched conditions: ADVANCED SOLID MALIGNANCY
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail shows promise against tough cancers
Disease control CompletedThis study tested combinations of the immunotherapy drug durvalumab with other drugs (danvatirsen, AZD5069, or tremelimumab) in 340 adults with advanced solid tumors or head and neck cancer. The goal was to find safe doses and see if the combinations shrink tumors. The trial has …
Matched conditions: ADVANCED SOLID MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC